Applied DNA Sciences (APDN) Gets a Hold Rating from Maxim Group


In a report released today, Anthony Vendetti from Maxim Group maintained a Hold rating on Applied DNA Sciences (APDN). The company’s shares opened today at $0.49, close to its 52-week low of $0.30.

Vendetti wrote:

“On February 7, 2019, APDN reported F1Q19 (Dec) revenue and GAAP loss per share figures that were weaker than expected.”

According to TipRanks.com, Vendetti is a 4-star analyst with an average return of 4.8% and a 49.8% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Restoration Robotics Inc, Xtant Medical Holdings, and Ra Medical Systems Inc.

The the analyst consensus on Applied DNA Sciences is currently a Hold rating.

See today’s analyst top recommended stocks >>

The company has a one-year high of $1.84 and a one-year low of $0.30. Currently, Applied DNA Sciences has an average volume of 563.3K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts